{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:19:50Z","timestamp":1790623190417,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cbi.2019.06.025","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T02:42:15Z","timestamp":1560307335000},"page":"108712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Aerosolized recombinant human butyrylcholinesterase delivered by a nebulizer provides long term protection against inhaled paraoxon in macaques"],"prefix":"10.1016","volume":"309","author":[{"given":"Yvonne","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"MacLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Ooms-Konecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Gerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayanan","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.06.025_bib1","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-99875-1","article-title":"Cholinesterases and anticholinesterase agents","author":"Koehle","year":"1963"},{"key":"10.1016\/j.cbi.2019.06.025_bib2","series-title":"International Encyclopedia of Pharmacology and Therapeutics","first-page":"1","article-title":"Anticholinesterase agents","author":"Karczmar","year":"1970"},{"key":"10.1016\/j.cbi.2019.06.025_bib3","series-title":"In Goodman and Gilman's Pharmacological Basis of Therapeutics","first-page":"239","article-title":"Anticholinesterases","volume":"vol 10","author":"Taylor","year":"2017"},{"key":"10.1016\/j.cbi.2019.06.025_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00139709-200322030-00003","article-title":"Human parathion poisoning. A toxicokinetic analysis","volume":"22","author":"Eyer","year":"2003","journal-title":"Toxicol. Rev."},{"key":"10.1016\/j.cbi.2019.06.025_bib5","article-title":"Oximes for acute organophosphate pesticide poisoning","volume":"2","author":"Buckley","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cbi.2019.06.025_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000104","article-title":"Pralidoxime in acute organophosphorus insecticide poisoning- a randomised controlled trial","volume":"6","author":"Eddleston","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.cbi.2019.06.025_bib7","doi-asserted-by":"crossref","first-page":"19422","DOI":"10.1074\/jbc.M111.230656","article-title":"New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases","volume":"286","author":"Sit","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2019.06.025_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0163-7258(90)90044-3","article-title":"Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine","volume":"47","author":"Lockridge","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2019.06.025_bib9","series-title":"In Chemical Warfare Nerve Agents Toxicity at Low Levels","article-title":"New approaches to medical protection against chemical warfare nerve agents","volume":"vols. 191\u2013214","author":"Doctor","year":"2001"},{"key":"10.1016\/j.cbi.2019.06.025_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cbi.2005.10.025","article-title":"Protection against soman or VX poisoning by human butyrylcholinesterase in Guinea pigs and cynomolgus monkeys","volume":"157\u2013158","author":"Lenz","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.06.025_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bcp.2010.09.007","article-title":"Prophylaxis with human serum butyrylcholinesterase protects Guinea pigs exposed to multiple lethal doses of soman or VX","volume":"81","author":"Saxena","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.06.025_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/jpet.102.033746","article-title":"Wild-type and A328W mutant human butyrylcholin-esterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity","volume":"303","author":"Duysen","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.06.025_bib13","doi-asserted-by":"crossref","first-page":"13603","DOI":"10.1073\/pnas.0702756104","article-title":"Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning","volume":"104","author":"Huang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2019.06.025_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cbi.2008.04.012","article-title":"Increased organophosphate scavenging in a butyrylcholin-inesterase mutant","volume":"175","author":"Geyer","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.06.025_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cbi.2010.02.042","article-title":"Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycol-conjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model","volume":"187","author":"Rosenberg","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.06.025_bib16","series-title":"In Insecticides Basic and Others Applications","first-page":"79","article-title":"Development of a prophylactic butyrylcholinesterase bioscavenger to protect against insecticide toxicity using a homologous macaque model","author":"Rosenberg","year":"2012"},{"key":"10.1016\/j.cbi.2019.06.025_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.114.213645","article-title":"Investigation of evolved paraoxonase 1 variants for prevention of organophosphorus pesticide compound intoxication","volume":"349","author":"Mata","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.06.025_bib18","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s00204-015-1626-2","article-title":"Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro","volume":"90","author":"Goldsmith","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2019.06.025_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.toxlet.2016.07.004","article-title":"Single treatment of VX poisoned Guinea pigs with the phosphotriesterase mutant C23AL: intraosseous versus intravenous injection","volume":"258","author":"Wille","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2019.06.025_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/taap.1997.8160","article-title":"The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase","volume":"145","author":"Raveh","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2019.06.025_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.122.1.219","article-title":"Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis","volume":"122","author":"Geller","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.cbi.2019.06.025_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxlet.2010.10.009","article-title":"Kinetic analysis of interactions of paraoxon and oximes with human, Rhesus monkey, swine, rabbit, rat and Guinea pig acetylcholinesterase","volume":"200","author":"Worek","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2019.06.025_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cbi.2013.12.010","article-title":"Protection against paraoxon toxicity by an intravenous pretreatment with polyethylene-glycol-conjugated recombinant butyrylcholinesterase in macaques","volume":"210","author":"Rosenberg","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.06.025_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cbi.2015.09.021","article-title":"Pharmacokinetics and immunogenicity of a recombinant human butyrylcholinesterase bioscavenger in macaques following intravenous and pulmonary delivery","volume":"242","author":"Rosenberg","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.06.025_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cbi.2012.11.004","article-title":"Pulmonary delivery of an aerosolized recombinant butyrylcholinesterase pretreatment protects against aerosolized paraoxon insecticide","volume":"203","author":"Rosenberg","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.06.025_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/nyas.13106","article-title":"Creation of a protective pulmonary bioshield against inhaled organophosphates using an aerosolized bioscavenger","volume":"1374","author":"Rosenberg","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cbi.2019.06.025_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2213-0802-2-3","article-title":"The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update","volume":"2","author":"Laube","year":"2014","journal-title":"Transl. Respir. Med."},{"key":"10.1016\/j.cbi.2019.06.025_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2016.05.018","article-title":"Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin","volume":"234","author":"Respaud","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.cbi.2019.06.025_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-2797(99)00013-7","article-title":"Association of tetramers of human butyrylcholinesterase is mediated by conserved aromatic residues of the carboxy terminus","volume":"14","author":"Altamirano","year":"1999","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.06.025_bib30","first-page":"605","article-title":"Nebulization of antibodies against ricin poisoning by inhalation: drug and development","volume":"3","author":"Marchand","year":"2014","journal-title":"Respir. Drug Deliv."},{"issue":"4","key":"10.1016\/j.cbi.2019.06.025_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jat.2730","article-title":"Development and validation of a simple assay for the determin-ation of cholinesterase activity in whole blood of laboratory animals","volume":"33","author":"Naik","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.cbi.2019.06.025_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jamp.2015.1250","article-title":"Optimization and dose estimation of aerosol delivery to nonhuman primates","volume":"29","author":"MacLoughlin","year":"2016","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.cbi.2019.06.025_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/(SICI)1099-0496(199605)21:5<301::AID-PPUL5>3.0.CO;2-P","article-title":"Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia","author":"Fok","year":"1996","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.cbi.2019.06.025_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1203\/01.PDR.0000156244.84422.55","article-title":"Aerosol deposition in neonatal ventilation","volume":"58","author":"Dubus","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cbi.2019.06.025_bib35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1006\/mthe.2002.0698","article-title":"Deposition and expression of aerosolized rAAV vectors in the lungs of Rhesus macaques","volume":"6","author":"Beck","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cbi.2019.06.025_bib36","first-page":"121","article-title":"Prophylaxis against soman inhalation toxicity in Guinea pigs by pretreatment alone with human serum butyrylcholin-esterase","volume":"43","author":"Allon","year":"1998","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2019.06.025_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.toxlet.2017.10.025","article-title":"Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques","volume":"293","author":"Rosenberg","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2019.06.025_bib38","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.bcp.2011.09.019","article-title":"Pretreat-ment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in G\u00f6ttingen minipigs exposed to sarin vapor","volume":"82","author":"Saxena","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.06.025_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/biot.201300229","article-title":"Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologue","volume":"9","author":"Schneider","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.cbi.2019.06.025_bib40","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1407417","article-title":"A randomized, controlled trial of an aerosolized vaccine against measles","volume":"372","author":"Low","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719303321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719303321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:56:55Z","timestamp":1757858215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719303321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"alternative-id":["S0009279719303321"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.06.025","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aerosolized recombinant human butyrylcholinesterase delivered by a nebulizer provides long term protection against inhaled paraoxon in macaques","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108712"}}